STAT

MARCH 6, 2024

On Sunday, public health officials in two Michigan counties warned their residents that they may have been exposed to measles. In Wayne County , an adult who had contracted the virus abroad had been in health-related settings in Dearborn on two days last week — two urgent care clinics, a CVS pharmacy, and a hospital emergency department. Health officials in neighboring Washtenaw County issued a similar alert about a different case — also an adult, also infected abroad —

Hospitals 363

Hospitals 363

PharmaVoice

MARCH 6, 2024

Innovation in schizophrenia has been slow, and patients are often left with few options — but pharmas contribute to a robust lineup of candidates that could improve care.

206

206

STAT

MARCH 6, 2024

Micro and nanoplastics, tiny pieces of plastic scattered throughout the environment, have been increasingly found to be able to enter the body, raising questions about where they end up and how they affect people’s health. In a new study, researchers say they have for the first time detected these plastic pieces inside fatty plaques that accumulate in blood vessels and linked them to an increased rate of heart problems.

363

363

PharmaVoice

MARCH 6, 2024

An all-out blitz across U.S. courts is bolstering pharma’s goal to overturn Medicare drug price negotiations.

Drug Pricing 163

Drug Pricing 163

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MARCH 6, 2024

WASHINGTON — President Biden wants to more than double the size of Medicare’s new drug price negotiation program and will preview the plan in his State of the Union address, the White House announced Wednesday. While the current program will eventually allow Medicare to negotiate the prices of up to 20 drugs per year, Biden will propose increasing that number to 50, and bringing more drugs into the negotiation process sooner.

Drug Pricing 345

Drug Pricing 345

Drug Patent Watch

MARCH 6, 2024

GELATIN-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs. Buy Gelatin-Free Medicines on Amazon This guide is designed to provide information for healthcare providers to… The post GELATIN-Free Medicines: Which Drugs Contain GELATIN? appeared first on DrugPatentWatch - Make Better Decisions.

110

110

pharmaphorum

MARCH 6, 2024

Looking to automate your literature search and review process in pharmacovigilance? Learn how AI can streamline the detection and analysis of Adverse Events (AE) effectively.

109

109

STAT

MARCH 6, 2024

Cerner may have ceded U.S. business to reigning electronic health records market leader Epic Systems, but new owner Oracle plans to close the gap with cloud services from supply chain management to claims processing, a top Oracle Health executive tells STAT.  Epic and Cerner have long been in a head-to-head race for medical software contracts. The playing field changed in 2022 when Cerner merged with cloud titan Oracle , coinciding with a loss in its large health system customers in the U.S

Cerner 328

Cerner Hospitals 328

pharmaphorum

MARCH 6, 2024

Get to know Jorge Reis-Filho, Vice President of Cancer Biomarker Development at AstraZeneca, through this exclusive interview featuring 12 insightful questions. Gain insights into his role, career journey, and the latest advancements in cancer biomarker development.

108

108

STAT

MARCH 6, 2024

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis. Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

281

281

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

MARCH 6, 2024

A £650 million investment package by AstraZeneca in the UK has been held up by Chancellor Jeremy Hunt as a “vote of confidence” in the country’s life sciences sector. AZ is preparing to invest £450 million at its manufacturing site in Speke, Liverpool, to boost research, development and manufacturing of vaccines, including the construction of a new plant that will be powered by renewable energy, according to a government statement.

Packaging 108

Packaging Vaccines 108

STAT

MARCH 6, 2024

Thinking about messaging your physician about a weird rash? You may want to hold off on it. Some hospital systems have started charging patients for digital messages to their doctors via the electronic medical record, either a flat rate (like a copay) or on sliding scale depending on the time or complexity of the physician’s response. Sometimes it’s billed through an insurer, sometimes as a direct cost to the patient.

Hospitals 269

Hospitals Medical Records 269

Express Pharma

MARCH 6, 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) approved Vertex ’s exagamglogene autotemcel (Casgevy) in late 2023. Subsequently, it became the inaugural CRISPR-based drug for the hematological indications beta thalassemia and sickle cell disease (SCD). Despite this approval, the CRISPR landscape is dominated by oncology, which accounts for 30 per cent of all active CRISPR drugs.

Immunity 106

Immunity Immunization 106

STAT

MARCH 6, 2024

Headspace, which has built a growing digital health business around mindfulness, is joining forces with Meta to launch a meditation app for Quest, the social media giant’s virtual reality headset. Called Headspace XR, the newly launched VR app — developed with funding from Meta — guides users through meditation and other activities, like a Tai Chi-inspired movement game, meant to encourage mental wellbeing.

225

225

Pharmaceutical Commerce

MARCH 6, 2024

In this Pharmaceutical Commerce video interview, Emma Banks, CEO of ramarketing, discusses how the balance between onshoring and outsourcing will evolve, how long will the current slowdown in biotech investment likely last, and what factors might influence its duration.

105

105

STAT

MARCH 6, 2024

WASHINGTON — A Senate panel Wednesday passed a bill aimed at preventing certain Chinese companies from doing business in the United States. The sole no vote was by Sen. Rand Paul (R-Ky.), who worries that Congress is using anger toward China as a cover for advancing parochial interests. Many in Congress are worried the Chinese government and military are using the rising dominance of national companies to gather Americans’ genetic information, which could be used for reasons that r

Drug Development 191

Drug Development 191

Pharmaceutical Technology

MARCH 6, 2024

Demand for medicinal cannabis is increasing globally to treat a range of illnesses and conditions.

136

136

STAT

MARCH 6, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with news of another biotech megaround, the potential next big thing from Novo Nordisk, and an anti-aging dispute involving dogs.

Drug Pricing 156

Drug Pricing Drug Development 156

pharmaphorum

MARCH 6, 2024

NICE has turned down Sanofi’s Xenpozyme as a treatment for the rare disease acid sphingomyelinase deficiency (ASMD), creating a situation where access to the drug in the UK will depend on a patient’s address.

100

100

Express Pharma

MARCH 6, 2024

In this episode of the Express Pharma – Nutrify Today Boardroom series, Dr Brijesh Kapil, draws on his 30-plus years of experience, including assignments as Director Marketing & Sales at Procter & Gamble Health; and head of Ranbaxy’s Global Consumer Healthcare business to talk about how companies can position themselves in the global responsible nutraceutical industry.

97

97

pharmaphorum

MARCH 6, 2024

Sandoz has claimed the first FDA approvals for biosimilars of Amgen’s blockbuster bone disease therapy denosumab, but has not said when it plans to launch them onto the US market.

Biosimilars 98

Biosimilars 98

Outsourcing Pharma

MARCH 6, 2024

Hayley Crowe is executive vice president and general manager of Ecolabâs Global Life Sciences sector, comprised of Ecolabâs Purolite and pharma / personal care businesses. We sat down with Hayley to discuss how grief inspired her determination to make a difference and how she is helping female colleagues address their imposter syndrome and 'mental attack'.

105

105

Pharma Times

MARCH 6, 2024

The project will train a newly developed AI system on data collected from participating men and women

121

121

European Pharmaceutical Review

MARCH 6, 2024

The US Food and Drug Administration (FDA) has approved the first and only FDA-approved denosumab biosimilars, to treat all indications of the reference medicines. This means that Sandoz ’s Wyost ® (denosumab-bbdz) and Jubbonti ® (denosumab-bbdz) are interchangeable for all indications of reference medicines Xgeva ® (denosumab) and Prolia ® (denosumab).

Biosimilars 91

Biosimilars Dosage Labelling 91

Pharma Times

MARCH 6, 2024

CDH affects one in 5,000 babies born in the UK, impacting the foetus’ development of vital organs

Hospitals 115

Hospitals 115

The Pharmacist

MARCH 6, 2024

Primary care networks (PCNs) in England will be able to recruit an unlimited number of pharmacists under the Additional Roles Reimbursement (ARRS) scheme, as part of the new GP contract arrangements. When the ARRS scheme was first introduced in 2019, all PCNs were able to claim reimbursement for one whole-time-equivalent (WTE) clinical pharmacist, or two […] The post Cap lifted on ARRS pharmacist recruitment under new GP contract appeared first on The Pharmacist.

85

85

pharmaphorum

MARCH 6, 2024

Bayer CEO says company is “badly broken” by patent losses, litigation, debt levels, and bureaucracy, limiting its options for a break-up of the group.

92

92

Outsourcing Pharma

MARCH 6, 2024

Almac Group, a global leader in CDMOs, announced today (March 6) that it has unveiled two new purpose-built facilities at its headquarters in Northern Ireland.

110

110

Pharmaceutical Technology

MARCH 6, 2024

J&J submitted a new application to the EMA for the approval of its Darzalex combination therapy for multiple myeloma.

98

98

The Pharmacist

MARCH 6, 2024

Only a small proportion of patients are able to sustain remission of their type 2 diabetes by weight loss alone, a study has suggested. An analysis of more than 37,000 patients enrolled in a risk reduction programme in Hong Kong showed eight years after diagnosis only 6% had achieved lowered blood glucose through weight loss. […] The post Long-term type 2 diabetes remission through weight loss ‘unsustainable’ for most appeared first on The Pharmacist.

Diabetes 84

Diabetes 84

Outsourcing Pharma

MARCH 6, 2024

ClinOne, a leading provider of clinical trial technology, has unveiled what it calls a major enhancement to its platform, offering customers far more control and flexibility.

104

104

World Pharma News

MARCH 6, 2024

Scientists discover a new way to disarm a deadly protein that also appears in cancers of the lung, breast and colon. UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition. The new molecule permanently modifies a wily cancer-causing mutation, called K-Ras G12D, that is responsible for nearly half of all pancreatic cancer cases and appears in some forms of lung, breast and colon

80

80

BioPharma Dive

MARCH 6, 2024

Study results showed early signs of promise in Duchenne patients who are currently ineligible to receive Sarepta’s Elevidys, triggering a stock surge.

86

86

Pharmaceutical Technology

MARCH 6, 2024

Experience rapid pain relief with Sorrento Therapeutics' stable oral liquid pharmaceutical composition of celecoxib. Patent filed for effective pain management within 2 hours.

75

75

BioPharma Dive

MARCH 6, 2024

Incubated by RA Capital and backed by a wide array of investors, the startup is developing drugs that work differently than Vertex’s market-leading medicines.

73

73